Mark Howard Snyder - Feb 16, 2025 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
SVP, CHIEF LEGAL OFFICER
Signature
/s/ James R. Oehler, Attorney-in-Fact
Stock symbol
HALO
Transactions as of
Feb 16, 2025
Transactions value $
-$696,857
Form type
4
Date filed
2/18/2025, 06:41 PM
Previous filing
Feb 14, 2025
Next filing
Feb 21, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Options Exercise $0 +17.4K +116.04% $0.00 32.4K Feb 16, 2025 Direct
transaction HALO Common Stock Tax liability -$546K -9.37K -28.92% $58.29 23K Feb 16, 2025 Direct F1
transaction HALO Common Stock Options Exercise $0 +4.8K +20.82% $0.00 27.8K Feb 16, 2025 Direct
transaction HALO Common Stock Tax liability -$151K -2.58K -9.28% $58.29 25.3K Feb 16, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Performance Stock Units Options Exercise $0 -17.4K -100% $0.00 0 Feb 16, 2025 Common Stock 17.4K $0.00 Direct F3
transaction HALO Restricted Stock Units Options Exercise $0 -4.8K -33.33% $0.00 9.59K Feb 16, 2025 Common Stock 4.8K $0.00 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported disposition of 9,373 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F2 The reported disposition of 2,582 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F3 This transaction represents the vesting and settlement of performance stock units in shares of common stock of the issuer.
F4 This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.